Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025 Pastilles have overtaken oil as the second-most prescribed dosage form for medicinal cannabis through the Special […]
SAS-B approvals slow in August but pastille scripts continue to rise by Steve Jones September 3, 2025September 8, 2025
May SAS-B approvals slip from April record but still close to 20,000 by Steve Jones June 3, 2025June 3, 2025
SAS-B approvals hit all-time high in April as Tasmania spikes again by Steve Jones May 2, 2025May 2, 2025
SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
Growth of pastilles accelerates as SAS approvals get off to strong start in 2025 by Steve Jones February 17, 2025February 17, 2025
May SAS-B approvals hold steady as THC-only product remains dominant by Steve Jones June 3, 2024June 3, 2024
Pastilles gaining in popularity as SAS-B approvals maintain strong start to 2024 by Steve Jones May 6, 2024July 16, 2024
SAS-B August approvals see monthly increase but down 13% on last year by Steve Jones September 6, 2022September 6, 2022
